US FDA accepts New Drug Application for GSK’s momelotinib for treatment of myelofibrosis EP News Bureau Aug 19, 2022 Regulatory submission included data from the pivotal Momentum phase-III clinical trial that met all primary and key secondary…
US FDA approves CTI BioPharma’s bone marrow cancer drug Reuters Mar 3, 2022 The drug, Vonjo (pacritinib), belongs to a class of anti-inflammatory treatments called JAK inhibitors, and will compete with…
